Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007904
Abstract: Key Points • A CRISPR/Cas9 screen targeting RNA binding proteins identifies RBM12 as a novel HbF regulator.• RBM12-mediated HbF repression is BCL11A-independent and reliant on its RRM1 domain.
read more here.
Keywords:
characterization rbm12;
novel regulator;
identification characterization;
regulator ... See more keywords